Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01)
| קרן | National Cancer Institute/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 11/02/2022 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The purpose of this grant is to support collaborative research projects designed to address adverse sequelae of cancer therapies that persist and become chronic comorbidities or developas delayed posttreatment effects. Basic, translational, and/or clinical research projects are welcome.
Funding: No fixed limit Duration: 5 years
Research Authority due date: 10 days prior to submission LOI (encouraged) due dates: 30.8.19, 11.1.120, 30.8.20, 11.1.21, 20.8.21, 11.1.22 Full proposal due dates: 30.9.19, 11.2.20, 30.9.20, 11.2.21, 20.9.21, 11.2.22 |
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 31/07/2019 |
